Filtros de búsqueda

Lista de obras de Evanthia Diamanti-Kandarakis

"Menstrual irregularities in PCOS. Does it matter when it starts?"

artículo científico publicado en 2011

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills

artículo científico publicado en 2003

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile

artículo científico publicado en 1999

Accumulation of dietary glycotoxins in the reproductive system of normal female rats

artículo científico publicado en 2007

Advanced glycation end products interfere in luteinizing hormone and follicle stimulating hormone signaling in human granulosa KGN cells

artículo científico publicado en 2017

Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways

artículo científico publicado en 2015

Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?

artículo científico

Advanced glycation end-products and insulin signaling in granulosa cells

artículo científico publicado en 2015

Aging ovary and the role for advanced glycation end products

artículo científico publicado en 2016

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

artículo científico publicado en 2006

Androgens and Therapeutic Aspects of Antiandrogens in Women

Androgens and therapeutic aspects of antiandrogens in women

artículo científico publicado el 1 de julio de 1995

Androgens associated with advanced glycation end-products in postmenopausal women

artículo científico publicado en 2010

Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome

artículo científico publicado en 2009

Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome

artículo científico publicado en 2011

Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome

artículo científico publicado en 2014

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

scientific article published on 07 April 2010

Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients

scientific article published on 10 January 2008

Beta-thalassemia major and female fertility: the role of iron and iron-induced oxidative stress

artículo científico publicado en 2013

Brown tumor of the fibula: unusual presentation of an uncommon manifestation. Report of a case and review of the literature.

artículo científico publicado en 2007

CD40 expression and its association with low-grade inflammation in a Greek population of type 1 diabetic juveniles: evidence for differences in CD40 mRNA isoforms expressed by peripheral blood mononuclear cells

artículo científico publicado en 2009

Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2.

artículo científico publicado en 2005

Cerebral salt wasting syndrome in traumatic brain injury following therapeutic barbiturate coma ⬇️

artículo científico publicado el 9 de junio de 2011

Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls

artículo científico publicado en 2005

Conservative management of gynecologic diseases: insulin sensitizing agents in polycystic ovary syndrome

artículo científico publicado en 2003

Correlates between hyperinsulinism and hyperandrogenemia?

artículo científico publicado en 2008

Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

artículo científico publicado en 2016

Creatine phosphokinase in ectopic pregnancy revisited: significant diagnostic value of its MB and MM isoenzyme fractions

artículo científico publicado en 2006

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

artículo científico publicado en 2006

Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?

artículo científico publicado en 2014

Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases

artículo científico

Current aspects of antiandrogen therapy in women.

artículo científico publicado en 1999

Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management

artículo científico publicado en 2015

Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation

scientific article published on 26 January 2008

DIAGNOSIS OF ENDOCRINE DISEASE: Drug-induced endocrinopathies and diabetes: a combo-endocrinology overview

scientific article published on 01 August 2019

Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome

artículo científico publicado en 2010

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).

artículo científico publicado en 2001

Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS).

artículo científico publicado en 2008

Dietary glycotoxins affect scavenger receptor expression and the hormonal profile of female rats

artículo científico publicado en 2013

Distribution and characterization of cyclo (His-Pro)-like immunoreactivity in the human gastrointestinal tract

scientific article published on 01 March 1985

Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.

artículo científico publicado en 2014

Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

artículo científico publicado en 2016

Does polycystic ovary syndrome start in childhood?

artículo científico publicado en 2008

Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome

artículo científico publicado en 2006

Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?

artículo científico publicado en 2007

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study

artículo científico publicado en 2007

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome

artículo científico publicado en 2007

Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome

artículo científico publicado en 2007

Effect of percutaneous endoscopic gastrostomy on gastro-esophageal reflux in mechanically-ventilated patients

artículo científico publicado en 2006

Effect of sibutramine on weight reduction and insulin resistance in women with polycystic ovary syndrome

artículo científico publicado en 2009

Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome

artículo científico publicado en 2006

Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome

artículo científico publicado en 2005

Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

artículo científico publicado en 2012

Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease

scholarly article by Olga Papalou et al published 2019 in Frontiers in Endocrinology

Endocrine and metabolic aspects of the Wolfram syndrome ⬇️

artículo científico publicado el 1 de agosto de 2011

Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.

artículo científico publicado en 2010

Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects

artículo científico publicado en 2014

Endocrine-disrupting chemicals: an Endocrine Society scientific statement

artículo científico publicado en 2009

Endothelial function and arterial stiffness in sickle-thalassemia patients

artículo científico publicado en 2006

Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.

artículo científico publicado en 2005

European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire

artículo científico publicado en 2014

Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis

artículo científico publicado en 2007

Exercise and the stress system.

artículo científico publicado en 2005

Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond

artículo científico publicado en 2020

Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome

artículo científico publicado en 2004

Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth

artículo científico publicado en 2005

Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

artículo científico publicado en 2015

Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism

artículo científico publicado en 2008

High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article

artículo científico publicado en 2015

High incidence of thyroid cancer among patients with acromegaly

artículo científico publicado en 2016

Histidyl-proline diketopiperazine [cyclo(His-Pro)]: a new neuropeptide modulator of insulin and glucagon secretion

artículo científico publicado en 1984

Hormone replacement therapy and risk of malignancy

artículo científico publicado en 2004

Hormones in sports: growth hormone abuse

artículo científico publicado en 2004

How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?

scientific article published on 01 October 1998

Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS.

artículo científico publicado en 2006

Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy

artículo científico publicado en 2009

Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries

artículo científico

Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial.

artículo científico publicado en 2014

Impact of androgen and dietary advanced glycation end products on female rat liver

artículo científico publicado en 2015

Impact of diet-induced obesity in male mouse reproductive system: The role of advanced glycation end product-receptor for advanced glycation end product axis

artículo científico publicado en 2014

Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)

scientific article published on 01 January 2014

Implications and Future Perspectives of AGEs in PCOS Pathophysiology

artículo científico publicado en 2019

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls.

artículo científico publicado en 2009

Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy

artículo científico publicado en 2001

Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome

artículo científico publicado en 2005

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).

artículo científico publicado en 2008

Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance ⬇️

artículo científico publicado el 1 de septiembre de 2013

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin

artículo científico publicado en 2006

Indices of low-grade inflammation in polycystic ovary syndrome

artículo científico publicado en 2006

Industrial endocrine disruptors and polycystic ovary syndrome

artículo científico publicado en 2013

Inflammatory and endothelial markers in women with polycystic ovary syndrome

artículo científico publicado en 2006

Inositols in Polycystic Ovary Syndrome: An Overview on the Advances

scientific article published on 09 March 2020

Insulin Resistance and Polycystic Ovary Syndrome Through Life ⬇️

artículo científico publicado el 1 de enero de 2012

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications ⬇️

artículo científico publicado el 12 de octubre de 2012

Insulin resistance in PCOS.

artículo científico publicado en 2006

Insulin resistance in pheochromocytoma improves more by surgical rather than by medical treatment

artículo científico publicado en 2003

Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome

artículo científico publicado en 1995

Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome

scientific article published on 01 January 2000

Introduction to Endocrine Disrupting Chemicals--is it time to act?

artículo científico publicado en 2016

Is cardiovascular risk in women with PCOS a real risk? Current insights

artículo científico publicado en 2017

Is there an association between thyroid function abnormalities and breast cancer?

artículo científico publicado en 2016

Liver disease in adult transfusion-dependent beta-thalassaemic patients: investigating the role of iron overload and chronic HCV infection

scientific article published on 01 March 2013

Liver failure due to antithyroid drugs: report of a case and literature review ⬇️

artículo científico publicado el 18 de mayo de 2010

Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.

artículo científico publicado en 2008

Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue

artículo científico publicado en 2010

MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects

artículo científico publicado en 2016

MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview

artículo científico publicado en 2017

MECHANISMS IN ENDOCRINOLOGY: Nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women

artículo científico publicado en 2017

Metabolic syndrome and polycystic ovary syndrome... and vice versa

artículo científico publicado en 2009

Metabolic syndrome: a contemporary fuel excess syndrome and its specific impact in women

artículo científico publicado en 2007

Metformin administration improves endothelial function in women with polycystic ovary syndrome

artículo científico publicado en 2005

Metformin and polycystic ovary syndrome

artículo científico publicado en 2000

Metformin in polycystic ovary syndrome

article

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

artículo científico publicado en 2009

Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome

artículo científico publicado en 2000

Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes.

artículo científico publicado en 2016

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

artículo científico publicado en 2006

Multiple tuberculous abscesses and mediastinal lymphadenitis with no pulmonary involvement in an immunocompetent patient

artículo científico publicado el 1 de octubre de 2012

New perspectives in polycystic ovary syndrome

scientific article published on 01 October 1996

Novel strategies in the management of polycystic ovary syndrome

artículo científico

Obesity and gonadal function of women

artículo científico publicado en 2004

Oral glucose tolerance test in patients with undiagnosed diabetes and coronary artery disease: when should it be performed?

artículo científico publicado en 2012

Oxidative Stress in Polycystic Ovary Syndrome

artículo científico publicado en 2016

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

artículo científico publicado en 2011

PCOS in adolescents

artículo científico publicado en 2009

Pancreatic beta-cells dysfunction in polycystic ovary syndrome.

artículo científico publicado en 2008

Pathophysiology and types of dyslipidemia in PCOS.

artículo científico publicado en 2007

Peroxisome proliferator‐activated receptor‐γ and ‐δ polymorphisms in women with polycystic ovary syndrome ⬇️

artículo científico publicado el 1 de septiembre de 2010

Phenotypes and Enviromental Factors: Their Influence in PCOS ⬇️

artículo científico publicado el 1 de enero de 2012

Plasma B-type natriuretic peptide concentration in beta-thalassaemia patients

artículo científico publicado en 2007

Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome

artículo científico publicado en 2006

Plasma visfatin levels in normal weight women with polycystic ovary syndrome

artículo científico publicado en 2008

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al

artículo científico publicado en 2013

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al

article

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

artículo científico publicado en 2013

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al

artículo científico publicado en 2013

Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review

artículo científico publicado en 2019

Polycystic Ovary Syndrome: Definitions, Phenotypes and Diagnostic Approach ⬇️

artículo científico publicado el 18 de octubre de 2012

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

artículo científico publicado en 2008

Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome

artículo científico publicado en 2007

Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).

artículo científico publicado en 2016

Polycystic ovary syndrome and environmental toxins

artículo científico publicado en 2016

Polycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspring

artículo científico publicado en 2012

Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis

artículo científico publicado en 2006

Polycystic ovary syndrome--phenotypes and diagnosis

artículo científico publicado en 2014

Polycystic ovary syndrome: the influence of environmental and genetic factors

artículo científico publicado en 2006

Polymorphism T-->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome

artículo científico publicado en 1999

Postprandial dysmetabolism: Too early or too late?

artículo científico publicado en 2016

Preface

artículo científico publicado en 2015

Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance

artículo científico publicado en 2004

Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome

artículo científico publicado en 2014

Primary adrenal lymphoma presented with adrenal insufficiency

scientific article published on 01 January 2004

Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome

artículo científico publicado en 2013

Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

scientific article published on 28 April 2020

Receiver operator characteristics and diagnostic value of progesterone and CA-125 in the prediction of ectopic and abortive intrauterine gestations

artículo científico publicado en 2005

Reprint of: policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

artículo científico publicado en 2013

Reprint of: policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich, et al.

artículo científico publicado en 2013

Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold?

artículo científico publicado en 2012

Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome

artículo científico publicado en 2008

Role of obesity and adiposity in polycystic ovary syndrome

artículo científico publicado en 2007

Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma

artículo científico publicado en 2003

Serum and seminal plasma ghrelin levels in men with normospermia and dyspermia

artículo científico publicado en 2008

Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?

artículo científico publicado en 2008

Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome

artículo científico publicado en 2010

Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome

artículo científico publicado en 2005

Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome

artículo científico publicado en 2005

Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome

artículo científico publicado en 2006

Stress in women: metabolic syndrome and polycystic ovary syndrome

artículo científico publicado en 2006

Structural, Biochemical and Non-Traditional Cardiovascular Risk Markers in PCOS ⬇️

artículo científico publicado el 1 de enero de 2013

Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?

artículo científico publicado en 2010

Tailoring treatment for PCOS phenotypes

scientific article published on 31 December 2020

Targets to treat metabolic syndrome in polycystic ovary syndrome

artículo científico publicado en 2015

The 88th Annual Meeting of the Endocrine Society, June 24-27, 2006, Boston MA, USA: selected pediatric presentations

artículo científico publicado en 2008

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

scientific article published on 23 October 2008

The Effect of a Pure Antiandrogen Receptor Blocker, Flutamide, on the Lipid Profile in the Polycystic Ovary Syndrome ⬇️

artículo científico publicado el 1 de agosto de 1998

The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications

artículo científico publicado en 2006

The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond ⬇️

artículo científico publicado el 1 de enero de 2011

The Polycystic Ovary Syndrome Pathogenesis, Metabolic Implications, and Therapeutic Approach ⬇️

artículo científico publicado el 17 de junio de 1997

The Role of Androgen Excess on Insulin Sensitivity in Women

scientific article published on 09 September 2019

The acute effect of Orlistat on dietary glycotoxins in diabetics and healthy women.

artículo científico publicado en 2009

The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers

scientific article published on 01 October 2014

The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome

artículo científico publicado en 2009

The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome

artículo científico publicado en 2009

The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome

artículo científico publicado en 2008

The effects of old, new and emerging medicines on metabolic aberrations in PCOS ⬇️

artículo científico publicado el 1 de febrero de 2012

The impact of endocrine disruptors on endocrine targets

artículo científico publicado en 2010

The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia ⬇️

artículo científico publicado el 14 de septiembre de 2010

The influence of obesity on hyperandrogenism and infertility in the female

artículo científico publicado en 2001

The knowledge of osteoporosis risk factors in a Greek female population

artículo científico publicado en 2008

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

artículo científico publicado en 2014

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels

artículo científico publicado en 2004

The role of genes and environment in the etiology of PCOS.

artículo científico publicado en 2006

The role of kisspeptin/GPR54 in the reproductive system

artículo científico publicado el 1 de mayo de 2011

The role of stress in PCOS

artículo científico publicado en 2016

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome ⬇️

artículo científico publicado el 1 de marzo de 1998

Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.

artículo científico publicado en 2007

Update on polycystic ovary syndrome

artículo científico publicado en 2006

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome

artículo científico publicado en 2014

Waldenström's macroglobulinemia developing in a patient with multiple sclerosis: coincidence or association?

artículo científico publicado en 2004

White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda